Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Management of dyslipidemia]

E Bruckert, F Dairou, G Turpin

    Presse Medicale (Paris, France : 1983)
    |September 2, 1995
    PubMed
    Summary

    Managing hyperlipidemia requires a personalized approach due to varying treatment efficacy and patient compliance. Our clinic

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Hypercholesterolemia, from screening to treatment: Who, why and how to manage].

    La Revue de medecine interne·2020
    Same author

    Psychological predictors of the combined adoption of physical exercise and dietary change among adults with hypercholesterolemia.

    Revue d'epidemiologie et de sante publique·2018
    Same author

    Lipoprotein-associated phospholipase A₂ activity is increased in patients with definite familial hypercholesterolemia compared with other forms of hypercholesterolemia.

    Nutrition, metabolism, and cardiovascular diseases : NMCD·2018
    Same author

    [Statin treatment must be personalized].

    La Revue de medecine interne·2018
    Same author

    [Familial hypercholesterolemia: A largely underestimated cardiovascular risk].

    Annales de cardiologie et d'angeiologie·2017
    Same author

    Consensus statement on the management of dyslipidaemias in adults.

    Annales d'endocrinologie·2017

    Area of Science:

    • Cardiovascular Medicine
    • Lipidology
    • Preventive Cardiology

    Background:

    • Established link between blood lipids and coronary artery disease (CAD).
    • Dietary modification and hypolipidemic drugs reduce coronary events but lack a cure for primary dyslipidemias.
    • Treatment effectiveness varies significantly between high-risk and moderate-risk patients, with generally low patient compliance.

    Discussion:

    • Hyperlipidemia management necessitates a rigorous, individualized strategy focusing on global risk assessment.
    • Patient education, detection of secondary hyperlipidemias, and comprehensive risk evaluation are crucial components.
    • Non-invasive atherosclerosis assessment aids in tailoring treatment plans.

    Key Insights:

    • A proactive, multi-faceted approach to hyperlipidemia care improves patient outcomes.
    • Global risk evaluation, including non-invasive atherosclerosis detection, is vital for effective management.
    • Early identification of secondary causes and patient education enhance treatment adherence.

    Outlook:

    • Further research into optimizing individualized treatment strategies for diverse patient populations.
    • Development of novel therapies to address primary dyslipidemias and improve long-term compliance.
    • Integration of advanced non-invasive techniques for more precise cardiovascular risk stratification.

    Related Experiment Videos